SUBSCRIBE

Breaking News on Biopharmaceutical Development & Manufacturing

Headlines > Bio Developments

Horizon to use CRISPR tech to enhance CHO cell lines for biomanufacturing

17-Jan-2017 - Horizon Discovery Group has extended its CRISPR technology license to improve the performance of CHO cell lines for biomanufacturing.

News in brief

Sartorius opens Shanghai validation testing lab

13-Jan-2017 - Sartorius has bolstered its process validation services through the opening of a new validation service laboratory at a site in China.

Takeda in $125M deal for startup’s ‘unique’ Immuno-oncology platform

13-Jan-2017 - Takeda has inked a 5-year deal to finance development of T-cell therapy redirection platform from recently founded biotech, Maverick Therapeutics, with exclusive right to buy.

Amgen teams with Immatics on cancer immunotherapies

11-Jan-2017 - Amgen will manufacture, trial and sell cancer immunotherapies developed in collaboration with Immatics Biotechnologies GmbH under an agreement announced this week.

Orchard picks PharmaCell to make its autologous cell therapies

09-Jan-2017 - Orchard Therapeutics has selected Dutch CMO PharmaCell to manufacture products from its gene therapy pipeline.

OTCQB: PMCB

Cell-in-a-Box: PharmaCyte seeks FDA advice for inoperable cancer trial

06-Jan-2017 - PharmaCyte has announced a pre-application meeting with the US FDA, to advise on their investigational new drug (IND) filing for a clinical trial its live cell encapsulation therapy.

Pfizer licenses cell lines from preclinical CRO, Absorption Systems

05-Jan-2017 - Absorption Systems has announced a technology licensing agreement with Pfizer Inc., in which the pharma company will use the preclinical CRO’s cell lines to test potential drug candidates.

Bruker buys mAb and immunoassay supplier InVivo

05-Jan-2017 - Bruker has bolstered its molecular biologics and mass spectrometric offering through the acquisition of contract manufacturing organisation (CMO) InVivo Biotech.

CrownBio expands into Louisiana primate research center with $1m facility

04-Jan-2017 - Crown Bioscience will invest $1m into a new subsidiary in Louisiana state to work alongside a new research facility at the New Iberia Research Center (NIRC).

Pfizer turns to Charles Stark Draper Laboratory for 'organ-on-a-chip' tech

22-Dec-2016 - The Charles Stark Draper Laboratory Inc. has inked a three year partnership with Pfizer to create personalised versions of Draper’s Microphysiological Systems (MPS), for cheaper and more effective preclinical testing....

BioCity CRO creates new Bioanalysis space with Thermo Scientific

20-Dec-2016 - XenoGesis has upgraded its spectroscopy capabilities in a deal with Thermo Fisher Scientific Inc. 

GSK opens first US vaccine R&D site in Maryland next to non-profit public health unit

16-Dec-2016 - The new $50m facility will house 450 scientists in Rockville, Maryland to work across 12 vaccine development programmes, alongside the non-profit Biopreparedness organisation (BPO).

update

Sugar lumps? Excipient impurities may be risk to patients says researcher

14-Dec-2016 - Newly identified impurities in sugar excipients pose a risk to patients and could explain why some drugs fail safety tests according to scientists from the Netherlands.

Eurofins Genomics launches EXTREmers

14-Dec-2016 - Eurofins Genomics has launched its EXTREmer oligonucleotides in the US – adding another ‘tool’ to help researchers advance drug discovery.

Sartorius to expand recently acquired cell line business, Cellca

14-Dec-2016 - Sartorius Stedim Cellca has said it will build a laboratory at newly acquired site in Ulm, Germany and hire additional staff.

Bayer to be cell therapy player through $225m stem cell JV

13-Dec-2016 - Bayer has launched itself into the cell therapy space through a $225m joint venture focused on developing induced pluripotent stem cells (iPSC).

Sartorius awarded US patent for single-use biological 3D printer

09-Dec-2016 - While in its early stages, the three-dimensional printing device enclosed in a disposable system could ensure sterile manufacturing of miniaturised organ models or even bioprocessing equipment parts, says Sartorius.

Sartorius teams with Synpromics to increase CHO cell line stability

06-Dec-2016 - Synthetic biology firm Synpromics will use its PromPT promoter platform to increase stability and reduce the lead time for Sartorius Stedim Cellca’s CHO expression platform.

News in brief

Arrowhead fires CSO & Co-inventor of delivery tech responsible for clinical trial abandonment

02-Dec-2016 - Arrowhead Pharmaceuticals Inc. has also laid off its Chief scientific officer David Lewis - as part of the 34 staff cull - after several trials using delivery vehicle Ex1 were...

Thermo Fisher buys MTI-GlobalStem upping stem cell and reagent offering

30-Nov-2016 - Thermo Fisher has bolstered its stem cell technology and reagent business through the acquisition of MTI-GlobalStem.

MedImmune and Abpro team on Ang2-VEGF targeting antibody

29-Nov-2016 - AstrzaZeneca’s MedImmune has set up a spin-out company with Abpro that will develop a bi-specific antibody therapeutic.

WuXi AppTec inks new manufacturing services agreement with Lion Biotechnologies

29-Nov-2016 - Lion Biotechnologies has expanded its ‘favorable’ existing relationship with WuXi AppTec to manufacture its autologous cell therapy products.

LBRefresh

Labiotech Refresh: experts talk Juno deaths & orphan drug prices in Paris

29-Nov-2016 - Juno’s CAR T candidate, combatting antimicrobial resistance, and why you should start a biotech in France. Biopharma-Reporter presents the hot topics from last week's 'Labiotech Refresh' event in Paris. ...

Trouble for GlobeImmune as Gilead exits T Cell activation hep B vaccine deal

23-Nov-2016 - GlobeImmune has terminated the lease agreement on its manufacturing site after Gilead’s withdrew from a Phase II hepatitis B vaccine collaboration.

MIT’s Langer sells off excipients biotech to break into Biosimilar market

21-Nov-2016 - Eagle Pharmaceuticals Inc. has announced its intention to buy Arsia Therapeutics citing its formulation viscosity reduction platform as the driver for the deal.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...